Periodontal Therapeutic Market Analysis, Trends, Growth, Size, Share and Forecast 2022 To 2030
Market Highlights
Periodontal
Therapeutics Market Size was valued at USD 0.3 billion in 2022
and is projected to grow from USD 0.3 Billion in 2023 to USD 0.6 billion by
2030, exhibiting a compound annual growth rate (CAGR) of 10.3% during the
forecast period (2023 - 2030).
Periodontal disease is an infection that occurs around the
teeth which include gums, periodontal ligament and alveolar bone. The earliest
stage of periodontal is gingivitis infection that affects the gums. Periodontal
is mostly caused by bacteria in dental plaque sticky substance that forms on
teeth. Although bacterial plaque is the main cause of periodontal disease
several other factors such as medication, other diseases, and oral habit also
contributes to periodontal disease.
The increasing demand for local antibiotic has resulted in a
rise in research and development of local antibiotic. Owing to the increasing
incidences of diabetic patients there is a rise in the periodontal therapeutic
market. Whereas the rising prevalence of periodontal disorders and
technological advancement in therapeutics are some factors positively impacting
on the growth of this market. By segment systemic antibiotic will holds the
largest share of the market during the forecast period. Whereas local
antibiotic segment is expected to grow at the fastest rate due to decreasing
chances of formation of resistant bacteria following few side effects.
Increasing expenditure on oral health care services by the government
especially in developed countries is anticipated to boost the treatment market
for the periodontal disorder.
Segmentation
The global periodontal therapeutic market has been segmented
on basis of treatment type, types of periodontal and end-users.
·
Based on treatment types market is
segmented into two segments such as systematic antibiotics and local antibiotics.
Systematic antibiotics are further sub-segmented into doxycycline, minocycline,
metronidazole, and others. Local antibiotics are further segmented into
arestin, chlorhexidine, and others.
·
On basis of types of periodontal, the
market is segmented into three types such as chronic periodontitis, aggressive
periodontitis, necrotizing periodontal disease.
·
On basis of end-user market is further is
segmented into dental clinics and hospitals
·
The market has been segmented, by region,
into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Key Players
Some of the Global Periodontal
Therapeutics Market Players are, Tolmar Inc, Eli Lilly & Company,
Align Technology Inc., Dentsply International, 3M-ESPE, Ultradent Products
Inc., Nobel Biocare Holdings AG, Glidewell Laboratories, Inc., Orapharma, Kaken
Pharmaceutical, Valeant Pharmaceuticals Int. Inc, Den-Mat Holdings,
Mallinckrodt Pharmaceuticals, Purdue Pharma L.P., Teva Pharmaceutical
Industries Limited, and Fibrocell Sciences Inc.
Regional Analysis
A booming need for more oral hygiene appeal in the field of
periodontal treatment is being observed worldwide. The rising awareness
regarding oral hygiene and increasing incidence of the periodontal disorder
among people are factors responsible for the growth of the market in this
region.
The market in the Americas is expected to boost the global
periodontal therapeutic market owing to technological advancement and
increasing incidences of the periodontal disorder among diabetic patients.
According to recent findings from the Centers for Disease Control and
Prevention (CDC), half of Americans aged 30 or older have periodontitis, the
more advanced form of periodontal disease. This equals approximately 64.7
million Americans. This is largely attributed to the accessibility of an urban
healthcare infrastructure. The European market is expected to be the
second-largest due to government funding and support from the healthcare sector
coupled with the rising prevalence of the periodontal disorder. However,
Asia-Pacific is projected to dominate in terms of growth rate over the forecast
period owing to rising investment towards R&D activities and unhealthy lifestyle
which are resulting in an increased prevalence of obesity. Rising geriatric
population and the increasing prevalence of diabetes in this region have a
positive influence on the development of the periodontal therapeutic market in
this region. The Middle East and Africa
account for the smallest share due to lack of medical technology and poor
medical facilities. Emerging economies such as India and China are leading to
growth in demand for periodontal therapeutic owing to increasing number of healthcare
awareness programs, government investment in healthcare and favorable
healthcare insurance coverage. National Oral Health Programmed (NOHP) was
conceptualized by the Indian Dental Association to ensure optimal oral health
for all by increasing awareness, assuring excellent service and high-quality
dental care
Related Report-
·
Digital
Wound Measurement Devices Market Research Report – Forecast to 2027
·
Hydrophobic
Interaction Chromatography Market Research Report – Forecast to 2027
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment